Malignant mesothelioma
MONDO:0006292A malignant neoplasm of the pleura or peritoneum, arising from mesothelial cells. It is associated with exposure to asbestos.
Also known as: malignant mesothelial tumor, malignant mesothelial tumour, malignant mesothelioma, malignant mesothelioma (disease), malignant neoplasm of mesothelium, malignant neoplasm of the mesothelium, malignant tumor of mesothelium, malignant tumor of the mesothelium
2828 clinical trials for this condition and its sub-types, 37 tagged with Malignant mesothelioma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Malignant mesothelioma
-
Malignant pleural mesothelioma 71 trials · 75 incl. sub-types
2 sub-types
- Pleural epithelioid mesothelioma 8 trials
- Pleural sarcomatoid mesothelioma 2 trials
-
Malignant peritoneal mesothelioma 13 trials
-
Malignant epithelioid mesothelioma 5 trials · 12 incl. sub-types
1 sub-type
- Pleural epithelioid mesothelioma 8 trials
-
Malignant biphasic mesothelioma 2 trials · 5 incl. sub-types
1 sub-type
- Pleural biphasic mesothelioma 4 trials
-
Diffused pleural mesothelioma 3 trials
-
Sarcomatoid mesothelioma 2 trials · 3 incl. sub-types
2 sub-types
- Pleural sarcomatoid mesothelioma 2 trials
- Lymphohistiocytoid mesothelioma 0 trials
-
Localized pleural mesothelioma 2 trials
-
Malignant pericardial mesothelioma 0 trials
-
Mesothelioma of the tunica vaginalis 0 trials
-
Ovarian malignant mesothelioma 0 trials
-
Pleural mesothelioma in situ 0 trials
-
Engineered immune cells take aim at Mesothelin-Positive tumors
Disease control Stopped earlyThis trial tests a new cell therapy called TC-510 for people with advanced cancers that have a protein called mesothelin on their surface, including mesothelioma, ovarian cancer, and pancreatic cancer. TC-510 uses a patient's own immune cells, which are genetically modified to be…
Phase 1/2 • Sponsor: TCR2 Therapeutics • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Immune cell therapy tested for tough childhood cancers
Disease control Stopped earlyThis early-phase study tested a treatment using donated natural killer (NK) cells from cord blood, combined with chemotherapy, for children and young adults with solid tumors that returned or didn't respond to standard care. The goal was to find the safest dose and check for side…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Exercise program for advanced lung cancer patients shows promise
Symptom relief Stopped earlyThis study looked at whether a supervised exercise program is possible for people with advanced bronchial cancer or mesothelioma. The goal was to see if patients could complete at least 6 rehab sessions to help with weakness and poor quality of life caused by the disease and its …
Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC